Key Financial Data Of Group

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7298002

Concept 2024-04-01 to
2024-09-30
As at
2024-09-30
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2023-09-30
As at
2023-09-30
Key financial data of group
Business results of group
Net sales
3,811,000,000 JPY
7,738,426,000 JPY
3,618,388,000 JPY
Ordinary profit (loss)
-256,353,000 JPY
-161,857,000 JPY
-319,840,000 JPY
Net assets
11,946,516,000 JPY
12,026,073,000 JPY
12,032,325,000 JPY
Total assets
15,256,746,000 JPY
15,421,054,000 JPY
15,811,544,000 JPY
Basic earnings (loss) per share
-4.08
3.13
-6.42
Diluted earnings per share
Equity-to-asset ratio
0.7830 xbrli:pure
0.7798 xbrli:pure
0.7609 xbrli:pure
Net cash provided by (used in) operating activities
282,579,000 JPY
-107,338,000 JPY
108,673,000 JPY
Net cash provided by (used in) investing activities
-225,179,000 JPY
-2,352,000 JPY
78,066,000 JPY
Net cash provided by (used in) financing activities
-103,877,000 JPY
-104,986,000 JPY
-104,307,000 JPY
Cash and cash equivalents
3,618,168,000 JPY
3,664,647,000 JPY
3,961,757,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.